KYOTO, Japan , May 17, 2024 /PRNewswire/ -- OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture , Japan , announced its presence at Heart Rhythm 2024, the Annual Meeting of the Heart Rhythm Society (HRS) in the U.S. At Heart ...
Two years of echocardiographic data affirm positive effects of atrial shunt therapy on heart structure and function TEWKSBURY, Mass. , May 7, 2024 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the ...
Planning enters next phase as ABMS announces open comment period WASHINGTON , April 25, 2024 /PRNewswire/ -- Efforts by the American College of Cardiology, the American Heart Association, the Heart Failure Society of America, the ...
CHILLICOTHE, Ohio , Â April 23, 2024 /PRNewswire/ -- Jesse Patterson has always been more of a self-treatment type of guy when it comes to dealing with his health. So, when the normally active 73-year-old New Holland resident started ...
We are pleased to announce the 11th International Conference on Interventional Cardiology scheduled to take place on October 24-25 2024 in the picturesque city of Zurich Switzerland. This conference will serve as a premier platform for leading ...
AUSTIN, Texas , April 9, 2024 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center became the first in the nation to use a novel pulsed field ablation (PFA) system to treat ...
SUNNYVALE, Calif. , March 18, 2024 /PRNewswire/ -- Aquedeon Medical, Inc., a Silicon Valley pioneering medical device company specializing in novel cardiothoracic solutions, is pleased to announce a significant milestone with initiation of ...
HANGZHOU, China , March 7, 2024 /PRNewswire/ -- Zylox-Tonbridge (2190.HK, "the Company"), a leading medical device company in the peripheral and neurovascular interventional market in China , today announced a new strategic partnership with ...
Seed Financing was led by Broadview Ventures NOTTINGHAM, England , Feb. 20, 2024 /PRNewswire/ -- IsomAb Ltd, Â a UK-based biotechnology company, announced today the closing of a ÂŁ7.5 million (approximately US$9.4 million ) Seed ...
Panel of independent experts reviewed data from the TRILUMINATE™ pivotal trial demonstrating safety, effectiveness and quality-of-life benefits of the TriClip system An investigational device in the U.S., TriClip is approved in more than 50 ...
Cardiovascular disease , primarily driven by atherosclerosis ( ) or the accumulation of fats and cholesterol in artery walls, accounts for one in three global fatalities, establishing it as the foremost cause of death worldwide. A team at ...
Researchers from the Cardiac Regeneration and Heart Failure Research Group (ICREC) at the Germans Trias i Pujol Research Institute (IGTP) and the Heart Institute of the Germans Trias Hospital (iCor) have discovered beneficial effects of the novel ...
A recent study conducted by researchers at Brigham and Women’s Hospital and Duke University reveals that a genetic variation found in 3-4% of self-identified Black individuals in the U.S. significantly increases the risk of heart failure and death, ...
Cardiovascular disease remains a significant global health concern, with heart attacks and strokes leading causes of mortality worldwide. However, individuals can take proactive measures to safeguard their heart health through lifestyle adjustments ...
While OpenAI’s ChatGPT demonstrates proficiency in various medical assessments, it exhibits limitations in evaluating heart risk ( ). ChatGPT’s Reliability Questioned in Critical Health Assessments Research, published in the journal ...
Subscribe to our Free Newsletters!